- High gross margin of 71.8%
- Lower volatility than the market (beta 0.29)
- Highly efficient cash conversion (100% FCF/OCF ratio)
Big movements in VistaGen Therapeutics Inc stock price on Friday moving 18.14% between high and low
(Updated on Jun 26, 2026)
The VistaGen Therapeutics Inc stock price gained 13.85% on the last trading day (Friday, 26th Jun 2026), rising from $0.617 to $0.702. During the last trading day the stock fluctuated 18.14% from a day low at $0.625 to a day high of $0.738. The price has fallen in 5 of the last 10 days but is still up by 22.49% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 427 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $1.03 million.
The stock lies in the upper part of a very wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $0.703 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 8.82% during the next 3 months and, with a 90% probability hold a price between $0.593 and $0.765 at the end of this 3-month period.
VTGN Signals & Forecast
Mostly positive signals in the chart today. The VistaGen Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.659 and $0.618. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 31.19%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). VistaGen Therapeutics Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Support, Risk & Stop-loss for VistaGen Therapeutics Inc stock
VistaGen Therapeutics Inc finds support from accumulated volume at $0.690 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.113 between high and low, or 18.14%. For the last week, the stock has had daily average volatility of 13.43%.
Our recommended stop-loss: $0.677 (-3.60%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 11 days ago.)
Trading Expectations (VTGN) For The Upcoming Trading Day Of Monday 29th
For the upcoming trading day on Monday, 29th we expect VistaGen Therapeutics Inc to open at $0.688, and during the day (based on 14 day Average True Range), to move between $0.669 and $0.735, which gives a possible trading interval of +/-$0.0662 (+/-9.89%) up or down from last closing price. If VistaGen Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 9.89% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $0.690, some $0.0120 (1.71%) from the current price of $0.702, our system finds the risk reward attractive.
Is VistaGen Therapeutics Inc stock A Buy?
VistaGen Therapeutics Inc holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.
Current score:
7.309
Strong Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 29, 2026 - $0.688 ( 1.96%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
VTGN Performance
Trading levels for VTGN
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.80 | 14.18% |
| R2 | 0.758 | 8.01% |
| R1 | 0.732 | 4.20% |
| Price | 0.702 | |
| S1 | 0.645 | -8.13% |
| S2 | 0.618 | -11.94% |
| S3 | 0.575 | -18.10% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 0.702 | |
| S1 | 0.690 | -1.71% |
| S2 | 0.622 | -11.45% |
| S3 | 0.602 | -14.19% |
FAQ
Click here for our free guide on how to buy VistaGen Therapeutics Inc Stock.
Buy VTGN